Vision

Vision Management Philosophy

SG Biochem contributing to public health

As the happiness of life begins with health, our company has the mission
to make the happiest world where all mankind live well without suffering from disease.
SG Biochem is working with joy and passion.

As the happiness of life begins with health,
our company has the mission to make the happiest world where
all mankind live well without suffering from disease.
SG Biochem is working with joy and passion.

As the happiness of life begins with
health, our company has the mission
to make the happiest world where
all mankind live well without
suffering from disease.
SG Biochem is working with
joy and passion.

Characteristic

SG Biochem, a leader in the development of distinct pharmaceuticals.

Ability

SG Biochem is a qualified IP-R&D centered company that has all Incrementally
Modified Drug, Planning, Research, Development.
We are pursuing the development of differentiated pharmaceuticals which has market
competitiveness through the balance and harmony of each part.
SG Biochem is a qualified IP-R&D centered company that has all
Incrementally Modified Drug, Planning, Research, Development.
We are pursuing the development of differentiated
pharmaceuticals which has market competitiveness through
the balance and harmony of each part.
SG Biochem is a qualified IP-R&D
centered company that has all
Incrementally Modified Drug, Planning,
Research, Development.
We are pursuing the development
of differentiated pharmaceuticals which
has market competitiveness through the
balance and harmony of each part.
Planning
Founded on the basis of an organization of top pharmaceutical patent experts,
SG Biochem leads an exclusive and market-dominant Best Designed medicines.
Through the Ministry of Food and Drug Safety's pharmaceutical patent informatics business
in long business we have excellent planning capabilities in accurate patent analysis,
professional information collection, and establishment of patent invalidation/patent evasion strategies.

Reading the changes in the pharmaceutical market, planning products that reflect market needs,
and assessing market competitiveness to review development feasibility
are the most important factors in the success of a developed product.
Product planning based on accurate market information, evaluating the value of developed products,
and establishing market entry strategies are our main planning capabilities.
Our research capability has expertise and promptness.
Founded on the basis of an organization of top pharmaceutical
patent experts, SG Biochem leads an exclusive and
market-dominant Best Designed medicines.
Through the Ministry of Food and Drug Safety's pharmaceutical
patent informatics business in long business we have excellent
planning capabilities in accurate patent analysis,
professional information collection, and establishment of patent
invalidation/patent evasion strategies.

Reading the changes in the pharmaceutical market,
planning products that reflect market needs,
and assessing market competitiveness to review development
feasibility are the most important
factors in the success of a developed product.
Product planning based on accurate market information,
evaluating the value of developed products,
and establishing market entry
strategies are our main planning capabilities.
Our research capability has expertise and promptness.
Founded on the basis of an organization
of top pharmaceutical patent experts,
SG Biochem leads an exclusive and
market-dominant Best Designed medicines.
Through the Ministry of Food and Drug Safety's
pharmaceutical patent informatics business
in long business we have excellent planning
capabilities in accurate patent analysis,
professional information collection,
and establishment of patent
invalidation/patent evasion strategies.

Reading the changes in the pharmaceutical
market, planning products that reflect
market needs, and assessing marketc
competitiveness to review development
feasibility are the most important factors
in the success of a developed product.
Product planning based on accurate market
information, evaluating the value of developed
products, and establishing market entry
strategies are our main planning capabilities.
Our research capability has expertise and promptness.
Research
Our research capability has expertise and promptness in that we increase the likelihood
of product success through the mechanistic prediction of clinical usefulness and the verification
process at the preclinical stage, and complete products through Scale-up research.
Our research capability has expertise and promptness
in that we increase the likelihood of product success through
the mechanistic prediction of clinical usefulness and
the verification process at the preclinical stage,
and complete products through Scale-up research.
Our research capability has expertise and
promptness in that we increase the likelihood
of product success through the mechanistic
prediction of clinical usefulness and the
verification process at the preclinical stage,
and complete products through Scale-up research.
Development
We are pursuing strategies that can increase the value of the developed product by establishing clinical/approval
strategies for products through continuous consultation channels with relevant organizations for drug approval,
establishing an external cooperative network to conduct clinical trials, and efficiently controlling the cost
and time required for development.
We are pursuing strategies that can increase the value of the developed
product by establishing clinical/approval strategies for products through continuous
consultation channels with relevant organizations for drug approval,
establishing an external cooperative network to conduct clinical trials,
and efficiently controlling the cost and time required for development.
We are pursuing strategies that can
increase the value of the developed product by
establishing clinical/approval
strategies for products through continuous
consultation channels with relevant
organizations for drug approval,
establishing an external cooperative
network to conduct clinical trials,
and efficiently controlling the cost
and time required for development.